Xinting Sang

18PUBLICATIONS
19CO-AUTHORS
Haematological tumoursPredictive and prognostic markersChemotherapyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 27, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study.

Xiaokun Chen, Jiali Xing, Baoluhe Zhang

|Mar 24, 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.

Xiaokun Chen, Xiangan Wu, Wei Peng

|Oct 10, 2023
Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma.

Bao Jin, Yuxin Wang, Baoluhe Zhang

|Jul 18, 2023
Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery.

Lejia Sun, Xindi Ke, Ai Guan

|May 29, 2023
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.

Chengpei Zhu, Hu Li, Xiaobo Yang

|Apr 17, 2023
Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents.

Xuezhu Wang, Xu Yang, Jingnan Wang

Pageof 3

Frequent Collaborators

8 joint publications

Yilei Mao

5 joint publications

Shunda Du

4 joint publications

Haitao Zhao

2 joint publications

Xiao Liu